Author

Jake S. Megna

Observed names: J. Megna, JAKE MEGNA, Jake Megna, Jake S Megna

Institution: Regeneron (United States)

Observed institutions: Regeneron (United States), University at Buffalo, State University of New York

OpenAlex ID: A5009507024

Activin A directly impairs human cardiomyocyte contractile function indicating a potential role in heart failure development

2022 · Scott MacDonnell, Jake Megna, et al. · Frontiers in Cardiovascular Medicine · 14

Composition, Physicochemical and Biological Properties of Exosomes Secreted From Cancer Cells

2018 · Scott W. Ferguson, Jake S. Megna, et al. · Elsevier eBooks · 11

The Impact of the Human Monoclonal Antibody Regn13335 on Pdgf-b: a Potential, Novel Therapeutic Strategy for Pulmonary Arterial Hypertension

2025 · YINGLIN GAO, BHARATHI SUNDARAM, et al. · CHEST Journal · 1

Abstract 4367121: Functional Characterization of a Novel Natriuretic Peptide Receptor 1 Variant I751N Uncovers a New Mechanism of Blood Pressure Regulation

2025 · Qin Ruan, Jake Megna, et al. · Circulation

Platelet-derived Growth Factor-BB (PDGF-BB) Antagonist Monoclonal Antibody as a Therapy for Pulmonary Arterial Hypertension

2024 · Y. Gao, B. Sundaram, et al.

Abstract 14803: Activin A Directly Impaired Human IPSC-cardiomyocyte Contractility and Electrophysiology

2020 · Jake S Megna, Scott MacDonnell, et al. · Circulation

List of Contributors

2018 · Maria Abreu, Aamir Ahmad, et al. · Elsevier eBooks

Works count: 7

Citation count: 26

H-index: 2

I10-index: 2